The United Arab Emirates (UAE) has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said. The vaccine will be produced and distributed by a joint venture between the UAE’s Group 42 and China National Biotec Group (CNBG), a unit of China National …
Read More »UAE APPROVES SINOPHARM’S PROTEIN-BASED VACCINE
December 28, 2021